<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) on relapse, transplant-related mortality (TRM), disease-free survival (DFS), and overall survival (OS) after allogeneic transplantation for <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) (n = 4224) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) (n = 1517) in 4 groups: without GVHD, <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD (aGVHD) alone, <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD (cGVHD) alone, and aGVHD + cGVHD </plain></SENT>
<SENT sid="1" pm="."><plain>Examining GVHD as a time-dependent covariate, after myeloablative conditioning (MAC), cGVHD and aGVHD + cGVHD were associated with lower relapse (P &lt; .002) </plain></SENT>
<SENT sid="2" pm="."><plain>TRM was higher in <z:hpo ids='HP_0000001'>all</z:hpo> GVHD groups (P &lt; .0001); DFS and OS were lower with aGVHD ± cGVHD (P &lt; .0001) </plain></SENT>
<SENT sid="3" pm="."><plain>After reduced-intensity conditioning (RIC), relapse was lower in <z:hpo ids='HP_0000001'>all</z:hpo> GVHD groups (P &lt; .0001); TRM was increased and DFS and OS were reduced with any GVHD (P��&lt; .0001) </plain></SENT>
<SENT sid="4" pm="."><plain>In those surviving disease-free (≥1-year) after MAC, relapse risks were similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups and TRM was higher with any GVHD (P &lt; .0001) </plain></SENT>
<SENT sid="5" pm="."><plain>DFS and OS were lower with cGVHD and aGVHD + cGVHD (P &lt; .0006) </plain></SENT>
<SENT sid="6" pm="."><plain>After RIC, relapse was lower (P = .009) and TRM higher (P = .002) only with aGVHD + cGVHD </plain></SENT>
<SENT sid="7" pm="."><plain>DFS was similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups and OS worse with aGVHD + cGVHD </plain></SENT>
<SENT sid="8" pm="."><plain>After MAC, GVHD has an adverse effect on TRM with early modest augmentation of GVHD-associated graft-versus-<z:hpo ids='HP_0001909'>leukemia</z:hpo> (GVL) </plain></SENT>
<SENT sid="9" pm="."><plain>With RIC, GVHD-associated GVL may be important in limiting both early and late <z:hpo ids='HP_0001909'>leukemia</z:hpo> recurrence </plain></SENT>
</text></document>